CBIZ, Inc. (CBZ)
Last Price$72.71.4%
Market Cap$3,805.0M
CBZ Rating
CBZ Quality rating performance
CBZ Intrinsic Value
Key Highlights:
As of Mar 07, 2025 CBZ Relative Value is $47.5, which is overvalued by 34.6%, compared to current share price of $72.7.
As of Mar 07, 2025 CBZ DCF Value is $84.4, which is undervalued by 16.1%, compared to current share price of $72.7.
CBZ Share Price History
1W (7.1%)
1M (17.4%)
6M 10.7%
YTD 17.4%
1Y (4.6%)
3Y 85.0%
5Y 197.6%
10Y 716.3%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
CBZ Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$3,805.0M
$5,624.3M
$1,813.5M
$110.8M
Shares Outstanding
52M
Employees
713K
Growth (CAGR)
13.8%
(1.7%)
(7.05%)
21.8%
287.18%
Profitability
10.1%
4.1%
6.8%
6.1%
269.9%
Intrinsic Value
$65.6 (9.7% overvalued)
$84.2
$47.1
$229.1
14.6%
Return on Capital
Financial Health
$1,819.2M
16.4x
2.2x
103.0%
Dividends
Earnings
Apr 23, 2025
BEAT by 19.6%
BEAT by 9.5%
(465.2%)
7 Beat & 3 Miss
CBZ Stock Financials
CBZ Income Statement Metrics
Annual
Quarterly
LTM
CBZ Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$123.7M -19.4% YoY
Capital Expenditure (CAPEX)
$0.0 -44.0% YoY
Free Cash Flow (FCF)
$123.7M -15.1% YoY
CBZ Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$1,813.5M 14.0% YoY
Cost of revenue
$1,631.0M 19.4% YoY
Pre-tax income
$41.0M (75.3%) YoY
2.3% margin
CBZ Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$2,134.8M
Current assets ($835.7M, 39.1% of total)
$13.8M (0.6%)
$538.9M (25.2%)
Other current assets
$283.0M (13.3%)
Non-current assets ($1,299.0M, 60.9% of total)
$0.0 (0.0%)
$196.3M (9.2%)
$490.0M (23.0%)
Other non-current assets
$612.8M (28.7%)
Financial position
$219.5M
Cash & Short-term
Investments
Total Debt
CBZ Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
CBZ Earnings Surprises
Crunching data... Almost there!
CBZ Dividends
CBZ Dividend Yield
Crunching data... Almost there!
CBZ Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with CBZ
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$3,805.0M | 5.2 | $65.6 9.7% overvalued | (4.6%) | $1,813.5M | $110.8M | 14.0% | 6.1% | 10.1% | 2.5% | 103.0% | |
$82.8B | 7.6 | $64.3 68.3% overvalued | 30.0% | $9,940.5M | $1,855.0M | 8.1% | 18.7% | 48.8% | 27.1% | 66.3% | |
$77.8B | 6.4 | $106.8 39.9% overvalued | 14.6% | $7,249.2M | $1,849.3M | 5.9% | 25.5% | 32.8% | 18.2% | 25.4% | |
$25.3B | 7.3 | $160.1 58.9% undervalued | (21.2%) | $10.1B | $2,857.8M | 4.7% | 28.3% | 72.2% | 5.6% | 70.6% | |
$18.7B | 7.7 | $80.8 20.3% overvalued | 35.1% | $4,279.2M | $1,001.4M | 15.4% | 23.4% | 56.3% | 5.9% | 73.4% | |
$11.6B | 6.6 | $63.8 178.0% undervalued | (28.5%) | £10.2B | £988.6M | 68.9% | 9.7% | 14.0% | 13.9% | 116.6% | |
$9,517.2M | 5.2 | $42.7 18.7% undervalued | 14.5% | $17.5B | $484.6M | (6.0%) | 2.8% | 7.1% | 6.4% | 40.2% | |
$4,251.8M | 5.7 | $128.9 81.1% undervalued | (16.0%) | $5,381.8M | $280.7M | 8.0% | 5.2% | 22.9% | 11.2% | 5.4% | |
$3,894.3M | 5.8 | $155.8 25.6% overvalued | 25.0% | $2,438.7M | $186.4M | 6.7% | 7.6% | 30.8% | 6.7% | 3.2% | |
$3,453.2M | 5.3 | $139.8 155.8% undervalued | 28.5% | $8,359.3M | $167.2M | 3.2% | 2.0% | 34.8% | 3.7% | 81.5% | |
$2,171.4M | 5.2 | $1,369.0 10,162.2% undervalued | (17.0%) | $307.7B | $16.3M | 40,184.5% | 0.0% | 99.9% | (4.1%) | 2.2% |
FAQ
What is CBIZ, Inc. (CBZ) stock rating?
As of today, CBIZ, Inc. has a stock rating of 5 (out of 10), which is considered Good.
is CBIZ, Inc. (CBZ) a good stock to buy?
As of today, CBIZ, Inc. has a Good stock rating, which is 9.7% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.